| Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. | |
| | |
MedLine Citation:
|
PMID: 19681128 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hay-Wells syndrome, caused by mutations in the p63 gene, is an autosomal dominant ectodermal dysplasia with the main features of ankyloblepharon filiforme adnatum, ectodermal defects, and cleft lip/palate, from which the disorder's other name, AEC syndrome, is derived. The National Foundation for Ectodermal Dysplasias convened the International Research Symposium for AEC Syndrome on November 8-10, 2006, at Texas Children's Hospital/Baylor College of Medicine, Houston, TX with appropriate IRB approval. This multidisciplinary conference was the largest gathering of such patients to date and allowed us to further characterize dermatologic features of AEC syndrome, which included: sparse and wiry hair, nail changes, past or present scalp erosions, decreased sweat production, palmar/plantar changes, and unique pigmentary anomalies. Early recognition of the features of AEC syndrome and subsequent early diagnosis is important in minimizing invasive diagnostic studies, improving morbidity and mortality, and providing genetic counseling. Skin erosions, especially those of the scalp, were identified as the most challenging cutaneous aspect of this syndrome. Although the reasons for the skin erosions and poor healing are not known, mutations of p63 may lead to a diminished store of basal cells capable of replenishing the disrupted barrier. Therapeutic strategies currently under exploration include gene therapy, as well as epidermal stem cell therapy. Until then, gentle wound care and limiting further trauma seem to be the most prudent treatment modalities. |
| | |
Authors:
|
Meena R Julapalli; Richard K Scher; Virginia P Sybert; Elaine C Siegfried; Alanna F Bree |
Related Documents
:
|
663568 - Anophthalmia and agenesis of columnella, prolabium and premaxilla without hypotelorism-... 14755468 - Spondyloepimetaphyseal dysplasia of maroteaux (pseudo-morquio type ii syndrome): report... 15194948 - Expanding the phenotypic spectrum of lenz-majewski syndrome: facial palsy, cleft palate... 15239198 - Variable expressivity in a family with kabuki make-up (niikawa-kuroki) syndrome. 1366238 - Boerhaave's syndrome as a complication of pre-existent gastrointestinal disease. 8426488 - Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American journal of medical genetics. Part A Volume: 149A ISSN: 1552-4833 ISO Abbreviation: Am. J. Med. Genet. A Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-08-26 Completed Date: 2010-01-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101235741 Medline TA: Am J Med Genet A Country: United States |
Other Details:
|
Languages: eng Pagination: 1900-6 Citation Subset: IM |
Copyright Information:
|
(c) 2009 Wiley-Liss, Inc. |
Affiliation:
|
Texas Children's Hospital, Department of Pediatric Dermatology, Baylor College of Medicine, 6621 Fannin Street, Houston, TX 77030, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abnormalities, Multiple
/
diagnosis,
genetics,
pathology* Adolescent Adult Child Child, Preschool Cleft Lip / diagnosis, genetics, pathology* Cleft Palate / diagnosis, genetics, pathology* Ectodermal Dysplasia / diagnosis, genetics, pathology* Eyelids / abnormalities* Female Hair / pathology Humans Infant Male Nails / pathology Scalp / pathology Skin / pathology* Syndrome Trans-Activators / genetics Tumor Suppressor Proteins / genetics Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/TP63 protein, human; 0/Trans-Activators; 0/Tumor Suppressor Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel method for delivering the Amplatzer muscular VSD occluder in a patient with double outlet righ...
Next Document: Gene therapy and protein therapy of ectodermal dysplasias: a perspective.